Longeveron IncLGVN
Price$2.59

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $2.59Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 76.1%/yr (balance of the path).58.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 662.5%Yr 748.9%Yr 835.3%Yr 921.7%Yr 108.0%
76.1% → 8.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.5%Yr 127.0%Yr 136.5%Yr 146.0%Yr 155.5%Yr 165.0%Yr 174.5%Yr 184.0%Yr 193.5%Yr 203.0%
8.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)8.0%
Discount rate (cost of equity) 9.4%
Volatility vs market (adjusted beta)1.00

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetLongeveron IncLGVNHealth Care
Valuation
P/E—
P/S7.2×
P/B15.1×
EV / Revenue3.3×
EV / EBITDA-0.5×
Profitability
Gross margin66.7%
Operating margin-1,941.7%
Net margin-1,891.7%
FCF margin-1,566.7%
Returns
ROE-400.0%
ROA-221.2%
ROIC—
Growth
Revenue growth (YoY)-50.0%
5-yr fwd EPS growth58.8%
Financial strength
Debt / Equity0.00×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.